Obstetrics, gynecology and reproductive medicine guidelines

Osteoporosis

PubMed Free Full Text

Osteoporosis: prevention, treatment

Australia

• Department of Health and Ageing
  • Osteoporosis prevention - a new picture emerges [2008]

• Osteoporosis Australia
  • Preventing osteoporosis: outcomes of the Australian Fracture Prevention Summit (Osteoporosis Australia and the National Prescribing Service) [2002]

Belgium

• Belgian Bone Club
  • Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club [2011]
  • Extraskeletal benefits and risks of calcium, Vitamin D and anti-osteoporosis medications [2011]
  • Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club [2010]

Canada

• Journal of the Canadian Dental Association
  • Building Osteoporosis Prevention into Dental Practice [2012]

Europe

• European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis
  • The role of calcium and vitamin D in the management of osteoporosis [2008]

International

• Cochrane Library
  • Strontium ranelate for preventing and treating postmenopausal osteoporosis
  • Fluoride for treating postmenopausal osteoporosis
  • Exercise for preventing and treating osteoporosis in postmenopausal women

• International Osteoporosis Foundation
  • Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity [2009]
  • Cost-effectiveness of the treatment and prevention of osteoporosis - a review of the literature and a reference model [2007]
  • Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation [2005]

• Kidney Disease: Improving Global Outcomes
  • KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD–MBD) [2009]

• National Guideline Clearinghouse
  • KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD–MBD) [2009]

United Kingdom

• Health Technology Assessment
  • Vitamin K to prevent fractures in older women: systematic review and economic evaluation [2009]
  • The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women [2007]

• National Guideline Clearinghouse
  • Denosumab for the prevention of osteoporotic fractures in postmenopausal women. National Institute for Health and Clinical Excellence (NICE) [2010]
  • Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. National Institute for Health and Clinical Excellence (NICE) [2008]
  • Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women. National Institute for Health and Clinical Excellence (NICE) [2008]

• National Institute for Health and Clinical Excellence
  • Osteoporosis - secondary prevention including strontium ranelate [2011]
  • Osteoporosis - primary prevention [2011]
  • Osteoporotic fractures - denosumab [2010]

United States of America

• Agency for Healthcare Research and Quality
  • Treatment To Prevent Osteoporotic Fractures: An Update [2012]
  • Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis: Update of a 2007 Report [2012]

• American College of Physicians
  • Pharmacologic Treatment of Low Bone Density or Osteoporosis to Prevent Fractures: A Clinical Practice Guideline from the American College of Physicians [2008]

• National Guideline Clearinghouse
  • Management and prevention of osteoporosis. Michigan Quality Improvement Consortium [2012]
  • Osteoporosis: prevention and treatment. University of Michigan Health System [2011]
  • Osteoporosis and fracture prevention in the long-term care setting. American Medical Directors Association [2009]
  • Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians [2008]
  • Osteoporosis/fracture prevention clinical practice guidelines. Kaiser Permanente Care Management Institute [2008]

• University of Michigan Health System
  • Osteoporosis [2011]

Articles in journals

• American Family Physician
  • Denosumab (Prolia) for Treatment of Postmenopausal Osteoporosis [2012]
  • Pharmacologic Prevention of Osteoporotic Fractures [2004]

• Annals of Oncology
  • Prevention and treatment of side-effects of systemic treatment: bone loss [2010]

• Arthritis Research & Therapy
  • Progress in osteoporosis and fracture prevention: focus on postmenopausal women [2009]

• Australian Family Physician
  • Osteoporosis – prevention and detection in general practice [2012]
  • Osteoporosis – pharmacological prevention and management in older people [2012]
  • Strontium ranelate – Does it affect the management of postmenopausal osteoporosis? [2007]
  • Compliance with treatment in osteoporosis patients. An ongoing problem [2006]

• BMC Medicine
  • Targeted exercise against osteoporosis: A systematic review and meta-analysis for optimising bone strength throughout life [2010]

• BMC Musculoskeletal Disorders
  • The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women [2011]

• British Medical Journal
  • Drugs for pre-osteoporosis: prevention or disease mongering? [2008]
  • Treatment of postmenopausal osteoporosis [2003]
  • Preventing fractures in elderly people [2003]

• Bulletin of the NYU Hospital for Joint Diseases
  • Osteoporosis - new treatments and updates [2011]

• Bulletin of the World Health Organization
  • New approaches to pharmacological treatment of osteoporosis [2003]
  • Exercise interventions: defusing the world's osteoporosis time bomb [2003]

• Cadernos de Saúde Pública
  • Treatment of postmenopausal osteoporosis in women: a systematic review [2008]

• Calcified Tissue International
  • Adverse Reactions and Drug–Drug Interactions in the Management of Women with Postmenopausal Osteoporosis [2011]

• Canadian Medical Association Journal
  • Prevention of osteoporosis-related fractures among postmenopausal women and older men [2009]

• Cardiology Journal
  • Safety of pharmacotherapy of osteoporosis in cardiology patients [2010]

• Clinical Interventions in Aging
  • Potential role of odanacatib in the treatment of osteoporosis [2012]
  • Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients [2012]
  • Clinical utility of denosumab for treatment of bone loss in men and women [2011]
  • Once-yearly zoledronic acid in hip fracture prevention [2009]
  • Emerging treatments for postmenopausal osteoporosis – focus on denosumab [2009]
  • Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis [2009]

• Clinical Medicine & Research
  • Advances in Therapy for Osteoporosis [2003]

• Clinical Orthopaedics and Related Research
  • The Effect of Antiresorptives on Bone Quality [2011]

• Current Opinion in Rheumatology
  • Adherence to Osteoporosis Treatments: Room for Improvement [2009]

• Discovery Medicine
  • Sclerostin: A Novel Target for Intervention in the Treatment of Osteoporosis [2011]

• Endocrine Reviews
  • Osteoclast Activity and Subtypes as a Function of Physiology and Pathology—Implications for Future Treatments of Osteoporosis [2011]

• Endokrynologia Polska
  • Strontium ranelate in post-menopausal osteoporosis [2011]
  • Denosumab--a new option in the treatment of osteoporosis [2011]

• European Journal of Endocrinology
  • Osteoblasts in osteoporosis: past, emerging, and future anabolic targets [2011]
  • Denosumab for bone diseases: translating bone biology into targeted therapy [2011]

• Exercise and Sport Sciences Reviews
  • Physical Activity in Childhood May Be the Key to Optimizing Lifespan Skeletal Health [2012]

• Expert Opinion on Pharmacotherapy
  • Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene [2011]

• Expert Opinion on Therapeutic Patents
  • Farnesyl pyrophosphate synthase modulators: a patent review (2006 - 2010) [2011]

• Expert Opinion on Therapeutic Targets
  • Wnt Signaling as a Therapeutic Target for Bone Diseases [2009]

• Expert Reviews
  • The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis [2012]

• Hormones
  • Statins, bone formation and osteoporosis: hope or hype? [2012]
  • Targeting the osteoblast: approved and experimental anabolic agents for the treatment of osteoporosis [2011]

• Human Reproduction Update
  • Sex steroids and bone: current perspectives [2003]

• Journal of Biomedical Science
  • Role of carotenoid beta-cryptoxanthin in bone homeostasis [2012]

• Journal of Cellular Biochemistry
  • Growth factor control of bone mass [2009]

• Journal of Clinical Endocrinology & Metabolism
  • Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives [2012]

• Journal of Clinical Investigation
  • Regulation of bone mass by Wnt signaling [2006]

• Journal of Endocrinology
  • AMP-activated protein kinase pathway and bone metabolism [2012]

• Lancet
  • New Horizons in Osteoporosis [2011]

• Medical Journal of Australia
  • Treatment of osteoporosis: why, whom, when and how to treat [2004]

• Nature Reviews Drug Discovery
  • Emerging Therapeutic Opportunities for Skeletal Restoration [2011]

• Nutrition Research
  • Green Tea and Bone metabolism [2009]

• Osteoporosis International
  • The impact of pharmacist interventions on osteoporosis management: a systematic review [2011]

• Pharmacological Research
  • Green Tea and Bone Health: Evidence from Laboratory Studies [2011]

• Physiological Research
  • Nutrition as prevention and treatment of osteoporosis [2009]

• Reviews in Endocrine & Metabolic Disorders
  • Treatment of osteopenia [2012]

• Revista Brasileira de Reumatologia
  • Drugs for the management of osteoporosis: a review [2011]

• Swiss Medical Weekly
  • The future of osteoporosis treatment - a research update [2012]

{Related topics}

• Guidelines
  • Osteoporosis: vitamin D
  • Osteoporosis: parathyroid hormone
  • Osteoporosis: hormone replacement therapy
  • Osteoporosis: calcium, nutrition
  • Osteoporosis: bisphosphonates
  • Osteoporosis